Skip to main content
Clinical Trials/TCTR20240427008
TCTR20240427008
Recruiting
Phase 2

The use of narrow-band imaging to improve pathological margin in oral squamous cell carcinoma: A prospective randomized controlled trial

one0 sites96 target enrollmentApril 27, 2024

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Oral squamous cell carcinoma patients aged more than 18 years with Eastern Cooperative Oncology Group (ECOG) performance status 0-1 who are due to undergo surgical treatment at Maharaj Nakorn Chiang Mai Hospital between June 2022 and May 2024.
Sponsor
one
Enrollment
96
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 27, 2024
End Date
May 31, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
one

Eligibility Criteria

Inclusion Criteria

  • Oral squamous cell carcinoma patients aged more than 18 years with Eastern Cooperative Oncology Group (ECOG) performance status 0\-1 who are due to undergo surgical treatment.

Exclusion Criteria

  • Patients who have previous head and neck surgery or irradiation, extensive lesions unable to define mucosal resection margins around the tumor, distant metastatic disease, and cancer in other parts of the body.

Outcomes

Primary Outcomes

Not specified

Similar Trials